Correlation Between UroGen Pharma and Dow Jones
Can any of the company-specific risk be diversified away by investing in both UroGen Pharma and Dow Jones at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UroGen Pharma and Dow Jones into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between UroGen Pharma and Dow Jones Industrial, you can compare the effects of market volatilities on UroGen Pharma and Dow Jones and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UroGen Pharma with a short position of Dow Jones. Check out your portfolio center. Please also check ongoing floating volatility patterns of UroGen Pharma and Dow Jones.
Diversification Opportunities for UroGen Pharma and Dow Jones
-0.73 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between UroGen and Dow is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding UroGen Pharma and Dow Jones Industrial in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dow Jones Industrial and UroGen Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UroGen Pharma are associated (or correlated) with Dow Jones. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dow Jones Industrial has no effect on the direction of UroGen Pharma i.e., UroGen Pharma and Dow Jones go up and down completely randomly.
Pair Corralation between UroGen Pharma and Dow Jones
Given the investment horizon of 90 days UroGen Pharma is expected to generate 8.79 times more return on investment than Dow Jones. However, UroGen Pharma is 8.79 times more volatile than Dow Jones Industrial. It trades about 0.04 of its potential returns per unit of risk. Dow Jones Industrial is currently generating about 0.08 per unit of risk. If you would invest 859.00 in UroGen Pharma on August 27, 2024 and sell it today you would earn a total of 332.00 from holding UroGen Pharma or generate 38.65% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
UroGen Pharma vs. Dow Jones Industrial
Performance |
| Timeline |
UroGen Pharma and Dow Jones Volatility Contrast
Predicted Return Density |
| Returns |
UroGen Pharma
Pair trading matchups for UroGen Pharma
Dow Jones Industrial
Pair trading matchups for Dow Jones
Pair Trading with UroGen Pharma and Dow Jones
The main advantage of trading using opposite UroGen Pharma and Dow Jones positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UroGen Pharma position performs unexpectedly, Dow Jones can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dow Jones will offset losses from the drop in Dow Jones' long position.| UroGen Pharma vs. Eliem Therapeutics | UroGen Pharma vs. Inhibrx | UroGen Pharma vs. Celcuity LLC | UroGen Pharma vs. Enliven Therapeutics |
| Dow Jones vs. MI Homes | Dow Jones vs. Franklin Street Properties | Dow Jones vs. Summit Hotel Properties | Dow Jones vs. Portillos |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |